(1) The illegal importation and use of 3,4-
methylenedioxy methamphetamine (referred to in
this Act as ‘‘MDMA’’ or ‘‘Ecstasy’’) has increased
more than 400 percent during the past 3 years, as
evidenced by Ecstasy seizures by the United States
Customs Service.
(2) Some research has indicated that the use of
Ecstasy can cause long-lasting and perhaps perma-
nent damage to the serotonin system of the brain,
and can cause long-term problems with learning and
memory.
(3) Due to the popularity and marketability of
Ecstasy, and the skyrocketing use, seizures, and
deaths, greater emphasis needs to be placed on—
(A) the education of young people on the
negative health effects of Ecstasy (and other
club drugs) since the reputation of Ecstasy as
a ‘‘safe drug’’ is its most dangerous component;
(B) the education of State and local law
enforcement agencies and health care profes-
sionals and personnel regarding the growing
problem of Ecstasy use and trafficking;
(C) adequate funding for the National In-
stitutes of Health to support and report on re-
search that documents the health effects of Ec-
stasy use; and
(D) State and local government initiatives.
SEC. 3. GRANTS FOR ECSTASY ABUSE PREVENTION.
Section 506B(c) of title V of the Public Health Serv-
ice Act is amended by adding at the end the following:
‘‘(3) EFFECTIVE PROGRAMS.—
‘‘(A) IN GENERAL.—In addition to the pri-
ority under paragraph (2), the Administrator
shall give priority to communities that have
taken measures to combat club drug use, in-
cluding passing ordinances restricting rave
clubs, increasing law enforcement on Ecstasy,
and seizing lands under nuisance abatement
laws to make new restrictions on an establish-
ment’s use.
‘‘(B) STATE PRIORITY.—A priority grant
may be made to a State under this paragraph
on a pass-through basis to an eligible commu-
nity.’’.
SEC. 4. COMBATING ECSTASY AND OTHER CLUB DRUGS IN
HIGH INTENSITY DRUG TRAFFICKING AREAS.
(a) PROGRAM.—
(1) IN GENERAL.—The Director of the Office of
National Drug Control Policy shall use amounts
available under this section to combat the trafficking
of MDMA in areas designated by the Director as
high intensity drug trafficking areas.
(2) ACTIVITIES.—In meeting the requirement
in paragraph (1), the Director shall transfer funds
to assist anti-Ecstasy law enforcement initiatives in
high intensity drug trafficking areas, including as-
sistance for investigative costs, intelligence enhance-
ments, technology improvements, and training.
(b) AUTHORIZATION OF APPROPRIATIONS.—
(1) IN GENERAL.—There are authorized to be
appropriated to carry out this section—
(A) $15,000,000 for fiscal year 2002; and
(B) such sums as may be necessary for
each of the fiscal years 2003 through 2005.
(2) NO SUPPLANTING.—Any Federal funds re-
ceived under this section shall be used to supple-
ment, not supplant, non-Federal funds that would
otherwise be used to carry out activities funded
under this section.
(c) APPORTIONMENT OF FUNDS.—The Director shall
apportion amounts appropriated for a fiscal year pursuant
to the authorization of appropriations in subsection (b) for
activities under subsection (a) among and within areas
designated by the Director and based on the threat assess-
ments submitted by individual high intensity drug traf-
ficking areas.
SEC. 5. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN.
(a) IN GENERAL.—In conducting the national media
campaign under section 102 of the Drug-Free Media Cam-
paign Act of 1998 (112 Stat. 2681–752), the Director of
the Office of National Drug Control Policy shall ensure
that such campaign addresses the reduction and preven-
tion of abuse of MDMA and club and emerging drugs
among young people in the United States.
(b) AUTHORIZATION
OF APPROPRIATIONS.—There
are authorized to be appropriated to carry out this
section—
(1) $7,000,000 for fiscal year 2002; and
(2) such sums as are necessary for each of the
fiscal years 2003 through 2005.
SEC. 6. MDMA DRUG TEST.
There are authorized to be appropriated to the Office
of National Drug Control Policy such sums as are nec-
essary to commission a drug test for MDMA which would
meet the standards for the Federal workplace.
SEC. 7. NATIONAL INSTITUTE ON DRUG ABUSE REPORT.
(a) RESEARCH.—The Director of the National Insti-
tute on Drug Abuse (referred to in this section as the ‘‘Di-
rector’’) shall conduct research—
(1) that evaluates the effects that MDMA use
can have on an individual’s health, such as—
(A) physiological effects such as changes in
ability to regulate one’s body temperature, stim-
ulation of the cardiovascular system, muscle
tension, teeth clenching, nausea, blurred vision,
rapid eye movement, tremors, and other such
conditions, some of which can result in heart
failure or heat stroke;
(B) psychological effects such as mood and
mind altering and panic attacks which may
come from altering various neurotransmitter
levels such as serotonin in the brain;
(C) short-term effects like confusion, de-
pression, sleep problems, severe anxiety, para-
noia, hallucinations, and amnesia; and
(D) long-term effects on the brain with re-
gard to memory and other cognitive functions,
and other medical consequences; and
(2) documenting those research findings and
conclusions with respect to MDMA that are scientif-
ically valid and identify the medical consequences on
an individual’s health.
(b) INTERIM REPORT.—Not later than January 1,
2003, the Director shall provide an interim report on the
progress and current findings of the study required by this
section.
(c) FINAL REPORT.—Not later than January 1,
2004, the Director shall submit a report to the Congress.
(d) REPORTS PUBLIC.—The report required by this
section shall be made public.
(e) AUTHORIZATION
OF APPROPRIATIONS.—There
are authorized to be appropriated to carry out this
section—
(1) $100,000 for the interim assessment under
subsection (b); and
(2) $1,500,000 for the final report under sub-
section (c).
SEC. 8. INTERAGENCY ECSTASY/CLUB DRUG TASK FORCE.
(a) ESTABLISHMENT.—
(1) IN GENERAL.—The Director of the Office of
National Drug Control Policy shall establish a Task
Force on Ecstasy/MDMA and Emerging Club Drugs
(referred to in this section as the ‘‘task force’’)
which shall—
(A) design, implement, and evaluate the
education, prevention, and treatment practices
and strategies of the Federal Government with
respect to Ecstasy, MDMA, and emerging club
drugs; and
(B) specifically study the club drug prob-
lem and report its findings to Congress.
(2) MEMBERSHIP.—The task force shall—
(A) be under the jurisdiction of the Direc-
tor of the Office of National Drug Control Pol-
icy, who shall designate a chairperson; and
(B) include as members law enforcement,
substance abuse prevention, judicial, and public
health professionals as well as representatives
from Federal, State, and local agencies.
(b) RESPONSIBILITIES.—The responsibilities of the
task force shall be—
(1) to evaluate the current practices and strate-
gies of the Federal Government in education, pre-
vention, and treatment for Ecstasy, MDMA, and
other emerging club drugs and recommend appro-
priate and beneficial models for education, preven-
tion, and treatment;
(2) to identify appropriate government compo-
nents and resources to implement task force rec-
ommendations; and
(3) to make recommendations to the President
and Congress to implement proposed improvements
in accordance with the National Drug Control Strat-
egy and its budget allocations.
(c) MEETINGS.—The task force shall meet at least
once every 6 months.
(d) TERMINATION.—The task force shall terminate 3
years after the date of enactment of this Act.
(e) AUTHORIZATION
OF APPROPRIATIONS.—There
are authorized to be appropriated $1,000,000 to carry out
this section.
Æ